Literature DB >> 21864748

The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells.

Jean-Claude Henquin1.   

Abstract

This review outlines the two pathways that interact in β-cells to ensure temporal and amplitude control of insulin secretion by glucose. The most well known triggering pathway involves the following steps: acceleration of glucose metabolism, closure of ATP-sensitive potassium channels, depolarization, influx of Ca(2+) through voltage-gated calcium channels, and a rise in the concentration of cytosolic ionized Ca(2+) that triggers exocytosis of insulin-containing granules. This classic sequence is, however, incomplete. Additional mechanisms, involving other channels, are necessarily implicated in the production of the triggering Ca(2+) signal. It is also clear that the effect of glucose on insulin secretion would be poor if Ca(2+)-induced exocytosis was not markedly augmented (approximately doubled) through a metabolic amplifying pathway, mechanistically distinct from neurohormonal amplifying pathways. This metabolic amplifying pathway is physiologically relevant for both phases of glucose-induced insulin secretion and for the potentiation, by glucose, of insulin secretion triggered by non-metabolized secretagogues (e.g. arginine). Three important challenges for future studies will be to identify the additional targets mediating control of the triggering Ca(2+) signal by glucose, to elucidate the cellular mechanisms of the metabolic amplifying pathway and to determine the contribution of each pathway in the alterations of insulin secretion in type 2 diabetic patients.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864748     DOI: 10.1016/S0168-8227(11)70010-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  78 in total

1.  Arginine is preferred to glucagon for stimulation testing of β-cell function.

Authors:  R Paul Robertson; Ralph H Raymond; Douglas S Lee; Roberto A Calle; Atalanta Ghosh; Peter J Savage; Sudha S Shankar; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

2.  Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells.

Authors:  Karel A Erion; Charles A Berdan; Nathan E Burritt; Barbara E Corkey; Jude T Deeney
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

Review 3.  Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond.

Authors:  Tomasz Szkudelski; Katarzyna Szkudelska
Journal:  J Physiol Biochem       Date:  2014-11-30       Impact factor: 4.158

4.  mTORC1 to AMPK switching underlies β-cell metabolic plasticity during maturation and diabetes.

Authors:  Rami Jaafar; Stella Tran; Ajit N Shah; Gao Sun; Martin Valdearcos; Piero Marchetti; Matilde Masini; Avital Swisa; Simone Giacometti; Ernesto Bernal-Mizrachi; Aleksey Matveyenko; Matthias Hebrok; Yuval Dor; Guy A Rutter; Suneil K Koliwad; Anil Bhushan
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

5.  Rp-cAMPS Prodrugs Reveal the cAMP Dependence of First-Phase Glucose-Stimulated Insulin Secretion.

Authors:  Frank Schwede; Oleg G Chepurny; Melanie Kaufholz; Daniela Bertinetti; Colin A Leech; Over Cabrera; Yingmin Zhu; Fang Mei; Xiaodong Cheng; Jocelyn E Manning Fox; Patrick E MacDonald; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2015-06-10

6.  ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB.

Authors:  Michele Leduc; Joy Richard; Safia Costes; Dany Muller; Annie Varrault; Vincent Compan; Julia Mathieu; Jean-François Tanti; Gilles Pagès; Jacques Pouyssegur; Gyslaine Bertrand; Stéphane Dalle; Magalie A Ravier
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

7.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Authors:  Mourad Ferdaoussi; Xiaoqing Dai; Mette V Jensen; Runsheng Wang; Brett S Peterson; Chao Huang; Olga Ilkayeva; Nancy Smith; Nathanael Miller; Catherine Hajmrle; Aliya F Spigelman; Robert C Wright; Gregory Plummer; Kunimasa Suzuki; James P Mackay; Martijn van de Bunt; Anna L Gloyn; Terence E Ryan; Lisa D Norquay; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Richard G Kibbey; Jocelyn E Manning Fox; William F Colmers; Orian S Shirihai; P Darrell Neufer; Edward T H Yeh; Christopher B Newgard; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  How do reducing equivalents increase insulin secretion?

Authors:  Alan D Attie
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

9.  Combined Deletion of Slc30a7 and Slc30a8 Unmasks a Critical Role for ZnT8 in Glucose-Stimulated Insulin Secretion.

Authors:  Kristen E Syring; Kayla A Boortz; James K Oeser; Alessandro Ustione; Kenneth A Platt; Melanie K Shadoan; Owen P McGuinness; David W Piston; David R Powell; Richard M O'Brien
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

10.  A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.

Authors:  Michael A Kalwat; Stephanie M Yoder; Zhanxiang Wang; Debbie C Thurmond
Journal:  Biochem Pharmacol       Date:  2012-12-16       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.